MONT-SAINT-GUIBERT, Belgium, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Akkermansia Company, a pioneer in developing “next generation” probiotics and postbiotics, announced today that the Patent Trial and ...

Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ingredient approval with muscle health claim, positioning HealthBiome for dual-market ...

Akkermansia muciniphila is well-known for its role in gut and metabolic health, with research highlighting its benefits for weight management, inflammation reduction, and metabolic disease prevention.

This next-generation postbiotic delivers all the benefits without the challenges associated with live bacteria. "We are thrilled to introduce AKK001™ at Vitafoods," said Gene Bruno, Chief Science ...

The bacterium Akkermansia muciniphila, which lives in the human intestines, is linked to a range of health advantages. These benefits include, but are not confined to, improving gut health, bolstering ...

CHICAGO, March 26, 2025 /PRNewswire/ -- CJ BIO's BiomeNrich(TM) POST M005 is the first Akkermansia muciniphila-based ingredient to receive New Dietary Ingredient Notification (NDIN) acknowledgment ...

IRVINE, CA, UNITED STATES, May 14, 2025 /EINPresswire / -- Nutraland USA, Inc., a leading provider of plant-based, science-based nutritional ingredients, is proud to announce the launch of its ...